#1 Clinical Trials Search in Europe

Etoricoxib

Etoricoxib, also known by its brand name Arcoxia, is a medication that has been the subject of numerous clinical trials for its potential in treating various medical conditions. This article explores the use of etoricoxib in different clinical settings, from managing pain and inflammation to its effects on specific diseases. We’ll delve into the findings of several studies to understand how this drug may benefit patients across different medical scenarios.

Table of Contents

What is Etoricoxib?

Etoricoxib is a prescription medication that belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It is specifically known as a selective cyclooxygenase-2 (COX-2) inhibitor. Etoricoxib is marketed under various brand names, including Arcoxia, Tauxib, Algix, Exxiv, and Etozox[1][2].

How Does Etoricoxib Work?

Etoricoxib works by selectively blocking the COX-2 enzyme, which is responsible for producing substances in the body that cause pain and inflammation. By inhibiting this enzyme, etoricoxib helps reduce pain, swelling, and inflammation associated with various conditions. Unlike traditional NSAIDs, etoricoxib is designed to have fewer gastrointestinal side effects[3].

Conditions Treated with Etoricoxib

Etoricoxib is used to treat several conditions characterized by pain and inflammation, including:

  • Osteoarthritis: A common form of arthritis caused by wear and tear of joint cartilage[5]
  • Rheumatoid Arthritis: An autoimmune disease that causes inflammation in the joints[5]
  • Ankylosing Spondylitis: A type of arthritis that primarily affects the spine[9]
  • Gout: A form of arthritis caused by the buildup of uric acid crystals in the joints[5]
  • Acute Pain: Including postoperative pain and dental pain[1]

Dosage and Administration

The dosage of etoricoxib varies depending on the condition being treated:

  • For ankylosing spondylitis, the recommended dose is typically 90 mg once daily[9]
  • For osteoarthritis, rheumatoid arthritis, and chronic pain, doses may range from 30 mg to 90 mg once daily[10]
  • For acute pain and gout, higher doses of up to 120 mg once daily may be prescribed for short periods[5]

Etoricoxib is usually taken orally (by mouth) once a day, with or without food[1].

Effectiveness of Etoricoxib

Several clinical trials have demonstrated the effectiveness of etoricoxib in treating various conditions:

  • In patients with ankylosing spondylitis, etoricoxib has shown significant improvement in pain and function compared to placebo[9]
  • For postoperative pain after total knee replacement surgery, etoricoxib has been found to reduce pain and the need for additional pain medication[1][2]
  • In rheumatoid arthritis patients, etoricoxib has demonstrated effectiveness in reducing pain and improving joint function[10]

Potential Side Effects

While etoricoxib is generally well-tolerated, it can cause side effects in some patients. Common side effects may include:

  • Gastrointestinal issues (such as stomach discomfort or nausea)
  • Headache
  • Dizziness
  • Elevated blood pressure

More serious side effects, although rare, can include cardiovascular events and gastrointestinal bleeding. It’s important to discuss potential risks with your healthcare provider[5].

Special Considerations

There are some important considerations when using etoricoxib:

  • Cardiovascular Risk: Like other NSAIDs, etoricoxib may increase the risk of heart attack and stroke. This risk may be higher with longer use or in people with existing heart disease[5].
  • Gastrointestinal Protection: While etoricoxib is designed to have fewer gastrointestinal side effects than traditional NSAIDs, some patients may still require additional stomach protection[1].
  • Pregnancy and Breastfeeding: Etoricoxib should be avoided during pregnancy, especially in the third trimester, and while breastfeeding unless specifically recommended by a healthcare provider.
  • Interactions: Etoricoxib can interact with other medications, including blood thinners and certain blood pressure medications. Always inform your healthcare provider about all medications you are taking[5].
Aspect Details
Main Uses Rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute pain management
Dosage Range 30 mg to 120 mg daily, depending on the condition
Administration Oral tablets, typically once daily
Unique Applications Prevention of heterotopic ossification, Ramadan headache prevention, management of chemotherapy-induced pain
Potential Advantages Fewer gastrointestinal side effects compared to traditional NSAIDs
Study Durations Varied from a few days to several months
Outcome Measures Pain reduction, improvement in disease activity scores, quality of life assessments

FAQ

  • What is etoricoxib and how does it work? Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, which is a type of nonsteroidal anti-inflammatory drug (NSAID). It works by reducing the production of prostaglandins, substances in the body that cause pain and inflammation.
  • In which medical conditions has etoricoxib been studied? Etoricoxib has been studied in various conditions including rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute pain following surgery, and even in preventing heterotopic ossification after hip replacement surgery.
  • What are some potential benefits of etoricoxib over traditional NSAIDs? Etoricoxib, being a selective COX-2 inhibitor, may cause fewer gastrointestinal side effects compared to traditional NSAIDs. Some studies have explored its use in conditions where traditional NSAIDs might be less effective or have more side effects.
  • How is etoricoxib typically administered in clinical trials? In the clinical trials reviewed, etoricoxib was typically administered orally in tablet form. Dosages varied depending on the condition being treated, ranging from 30 mg to 120 mg daily, with treatment durations varying from a few days to several months.
  • Are there any unique applications of etoricoxib being explored? Yes, some unique applications being explored include its use in preventing Ramadan headaches, managing taxane-associated acute pain syndrome in breast cancer patients, and its potential role in periodontal treatment when combined with scaling and root planing.

Ongoing Clinical Trials on Etoricoxib

  • Study Comparing Infliximab and NSAID Drug Combination for Patients with Axial Spondyloarthritis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Effectiveness of Sphenopalatine Ganglion Block vs. Scalp Block in Patients Undergoing Craniotomy for Supratentorial Mass Using Levobupivacaine and Drug Combination

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium

  • Study on Pain Relief After Lumbar Spinal Surgery Using Erector Spinae Plane Block with Etoricoxib and Drug Combination for Patients Undergoing Lumbar Arthrodesis

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium

  • Study on Pain Relief After Wisdom Tooth Surgery Using Etoricoxib and Celecoxib for Patients Undergoing Mandibular M3 Removal

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary

  • Study on Post-Surgery Pain Relief for Radius Fracture Patients Using Ropivacaine and Oxycodone

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study on Pain Relief After Hip Replacement Surgery Using Morphine, Ropivacaine, and Bupivacaine for Patients Undergoing Spinal Anesthesia

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

Glossary

  • Heterotopic Ossification: The abnormal growth of bone in soft tissue, such as muscle or tendons, which can occur after certain types of surgery or injuries.
  • Ankylosing Spondylitis: A type of arthritis that primarily affects the spine, causing inflammation of the spinal joints that can lead to severe, chronic pain and discomfort.
  • Cyclooxygenase-2 (COX-2): An enzyme involved in the production of prostaglandins, which are responsible for inflammation and pain in the body. COX-2 inhibitors like etoricoxib specifically target this enzyme.
  • BASDAI (Bath Ankylosing Spondylitis Disease Activity Index): A standardized method used to determine the effectiveness of treatments for ankylosing spondylitis, consisting of a questionnaire that measures disease activity on a scale from 0 to 10.
  • Taxane-associated Acute Pain Syndrome (T-APS): A condition characterized by myalgia (muscle pain) and arthralgia (joint pain) that occurs as a side effect of taxane chemotherapy drugs used in cancer treatment.
  • Superoxide Dismutase (SOD): An important antioxidant enzyme in the body that helps protect cells from damage caused by harmful molecules called free radicals.
  • Scaling and Root Planing (SRP): A deep cleaning dental procedure used to treat periodontal disease by removing plaque and tartar from below the gum line and smoothing the roots of the teeth.

References

  1. https://clinicaltrials.gov/study/NCT02750917
  2. https://clinicaltrials.gov/study/NCT02534610
  3. https://clinicaltrials.gov/study/NCT02149758
  4. https://clinicaltrials.gov/study/NCT01022190
  5. https://clinicaltrials.gov/study/NCT01685424
  6. https://clinicaltrials.gov/study/NCT04565600
  7. https://clinicaltrials.gov/study/NCT01148303
  8. https://clinicaltrials.gov/study/NCT01091675
  9. https://clinicaltrials.gov/study/NCT00264147
  10. https://clinicaltrials.gov/study/NCT00945035